GWPRF News and Press, GW Pharmaceuticals

Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financial conditions. Owning the "Pharmland" - the physical real estate - had been one of the...

Merger activity remained steady last week with six new deals announced. Kansas City Southern receives new superior offer. Three new bank mergers announced last week. For further details see: Merger Arbitrage Mondays - Bank Mergers Dominate

Merck & Co. is a large legacy company that makes a profit, pays a consistent dividend, and is a familiar and dependable company. That sometimes makes for boring. Analysts have a consensus target price in the mid-$90s while it might be undervalued by over 50%. Merck develops an...

Flying High: The emerging Cannabis REIT sector has been far-and-away the best-performing property sector since the start of 2019, soaring more than 150% in 2020 following 70% gains the prior year. The momentum has continued this year after New York became the 15th state to fully legal...

Merger activity increased last week. The bidding war for Coherent comes to an end. The acquisition of MSG Networks (MSGN) by Madison Square Garden Entertainment. For further details see: Merger Arbitrage Mondays - Multiple Deals In Bidding Wars

The ETF tracks the largest and most promising Cannabis companies in North America, diversifying risk to investors. The Cannabis market is ever-growing as more countries and U.S. states are legalizing recreational use. While valuations of included companies are high, they are nowhe...

After a two-year dark night, a new dawn is here for cannabis investors. Cannabis companies have stronger fundamentals that will drive the sector higher over the next five years. Investors can now have more clarity about which companies have the greatest potential for growth. ...

Cannabis sales are determined by number of dispensaries and the availability to them by proximity. California has no restrictions regarding the number of dispensaries such as Washington State. Growth in cannabis in California will eclipse the entire cannabis industry's current ret...

Cannabis companies are starting to turn a profit and print positive EPS. Here are the few that are earning a profit. Many companies are close to turning a positive EPS. The industry itself is expected to expand some 100% in the next couple of years, and with economies of scale, th...

The cannabis sector is poised for great growth due to potential for more permissive regulations. US MSOs are better situated to gain from new regulations than their Canadian counterparts. An actively managed ETF play can be a good solution to avoid specific stocks in a turbulent s...